Symbiota has named David Perry as president and CEO to lead the company in its next phase of growth and commercialization. Symbiota is a pioneer of plant microbiome solutions that naturally promote crop health and improve agricultural production. Perry was most recently CEO and co-founder of Anacor Pharmaceuticals.
“I am thrilled to be chosen to lead Symbiota,” says Perry. “The company has made a breakthrough discovery that gives it an unmatched ability to develop natural products that improve crop health based on the science of the plant microbiome. I believe that Symbiota has the potential to create extraordinary economic value, and to enable the planet to make meaningful progress in feeding ourselves in a more sustainable way.”
